Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01915706 · ClinicalTrials.gov registry record · NA
The Effect of Scheduled Ripcord Removal on the Outcomes of Baerveldt 350 Implants
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT01915706 is a NA study that has completed, run by Duke University. The registered enrollment target is 81 participants.
The verdict
NCT01915706, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the post-operative complication rates and surgical outcomes in patients with a Baerveldt 350 implant following scheduled rip-cord removal in clinic at post-operative week 3 versus spontaneous tube opening. Patients age 18 or greater with uncontrolled glaucoma and scheduled to undergo their first superotemporal Baerveldt 350 implant will be recruited and randomized at the time of enrollment to either scheduled ripcord removal at post-operative week 3 or no ripcord removal. Incidence of complications will be documented and compared between the 2 groups. The final intraocular pressure control between the 2 groups will also be compared in a secondary outcome analysis. This study will help to establish post-operative management guidelines to minimize complications and improve intraocular pressure lowering success following Baerveldt 350 implantation.
Interventions
- PROCEDURE Ripcord removal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2013-09 |
| Est. Completion | 2017-09-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01915706
The ClinicalTrials.gov registry entry for NCT01915706 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ripcord removal is the first listed.
NCT01915706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01915706 about?
NCT01915706 is a clinical study titled "The Effect of Scheduled Ripcord Removal on the Outcomes of Baerveldt 350 Implants". The purpose of this study is to compare the post-operative complication rates and surgical outcomes in patients with a Baerveldt 350 implant following scheduled rip-cord removal in clinic at post-operative week 3 versus spontaneous tube opening. Patients age 18 or greater with uncontrolled glaucoma ...
What is the current status of trial NCT01915706?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2013-09. Estimated completion is 2017-09-19.
What interventions are being tested in trial NCT01915706?
The interventions under investigation include: Ripcord removal (PROCEDURE).
Who is sponsoring clinical trial NCT01915706?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.